General Dermatology

November is Hyperhidrosis Awareness Month - test your knowledge on the subject.

The study calls for improved diversity in clinical training materials to help future clinicians better recognize conditions on darker skin.

Join Dermatology Times in celebrating National Healthy Skin Month.

November is Hyperhidrosis Awareness Month - test your knowledge on the subject.

With the Affordable Care Act's uncertain future, many Americans are curious about Robert F. Kennedy Jr.'s potential role in the new administration.

Murase noted small molecule treatments, like JAK inhibitors, remain unsafe for pregnant women.

In a session at Elevate-Derm West, Cheever presented on the utilization of AI within dermatology to optimize patient communication and diversify research.

Learn more about the in-depth topics covered in the October 2024 print issue of Dermatology Times.

Motivators like health benefits, altruism, and trust in clinicians enhance participant retention and adherence in melanoma research, according to MEL-SELF findings.

Dermatology Times is looking back on the top stories in dermatology from the month of October.

Dermatology Times is recapping our top expert interviews from the month of October.

A pilot study monitored the disease management, technical challenges, and overall benefits for chronic spontaneous urticaria.

Personalized treatment strategies for infectious skin diseases are being developed using AI algorithms that analyze individual patient data.

A study of the new cleanser included diverse participants, ensuring it is suitable for various skin types and sensitivities.

Del Rosso reviews available and upcoming monoclonal antibodies, including nemolizumab, lebrikizumab, bimekizumab, and more.

The late-breaking data will be presented at ACAAI’s annual Scientific Meeting.

The application of a clinically validated moisturizer before mask-wearing was shown to significantly improve skin barrier function and reduce irritation.

Click here to answer today’s poll and read more about the perception of telehealth treatment in dermatology.

Researchers behind a recent study found that patients with liver disease had a significantly higher prevalence of chronic pruritus.

The multicenter trial reported high response rates and low risk of discontinuation for treating long-term chronic inducible urticaria.

Developed by a panel of global dermatology experts, the SQS addresses the multifaceted nature of skin quality.

Although further research is still needed, dermatologists and patients are generally satisfied with teledermatology treatment.

The app demonstrated high sensitivity (92.0%) and specificity (95.5%) in identifying skin changes through a controlled testing environment.

Efinaconazole demonstrated enhanced efficacy in treating nail fungal infections, thanks to its high penetration capability and low keratin binding.

Dermatology offers the power of choice, and it can be exactly what you make of it, writes our Fall Editor in Chief Raj Chovatiya, MD, PhD.

Join Dermatology Times in honoring World Mental Health Day on Oct 10, 2024.

The expanded dosage aims to provide healthcare providers with greater flexibility in treating larger or multiple areas affected by AK.

Researchers behind the review suggested that future research should prioritize large-scale trials to confirm abrocitinib's long-term safety and efficacy in various skin disorders.

Dermatology Times is looking back on the top stories in dermatology from the month of September.

Dermatology Times is recapping our top expert interviews from the month of September.